Merck's strong financial performance in oncology and vaccines drove a 9% sales increase earlier in Q1 of 2024. See why I rate ...

Dec. 3—WORTHINGTON — A partnership between Worthington's Cambridge Technologies, developers of autogenous vaccines in the ...

Merck & Co. (NYSE:MRK) is a global health care company that delivers innovative health solutions through its prescription ...

A partnership between Worthington’s Cambridge Technologies, developers of autogenous vaccines in the livestock and poultry industries, and Merck Animal Health, manufacturers of mass-produced ...

Rahway, New Jersey-based Merck & Co., Inc. (MRK) operates as a healthcare company worldwide. Valued at $256.4 billion by ...

Leerink Partners analyst Daina Graybosch has maintained their bullish stance on MRK stock, giving a Buy rating on December 11.Pick the best ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Merck & Company (MRK – Research Report), with a ...

The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive ...

Rabies is a deadly viral infection that spreads in the saliva of infected animals. When a rabid animal bites another animal ...